LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 513 | 10345 | 10349 | 0.9996 | 0.9998 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 513 | 9667 | 10483 | 0.9221 | 0.9631 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 513 | 9589 | 10254 | 0.9351 | 0.9692 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 2 | L04 | 72 | hr | 513 | 9636 | 10349 | 0.9311 | 0.9673 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 3 | L04 | 72 | hr | 513 | 9202 | 10483 | 0.8778 | 0.9410 |
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 1 | L03 | 72 | hr | 513 | 7969 | 10254 | 0.7771 | 0.8866 |
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 2 | L03 | 72 | hr | 513 | 7960 | 10349 | 0.7691 | 0.8824 |
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 3 | L03 | 72 | hr | 513 | 7430 | 10483 | 0.7087 | 0.8479 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 1 | L02 | 72 | hr | 513 | 1566 | 10254 | 0.1527 | 0.2946 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 2 | L02 | 72 | hr | 513 | 1734 | 10349 | 0.1675 | 0.3243 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 3 | L02 | 72 | hr | 513 | 1697 | 10483 | 0.1619 | 0.3162 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 1 | L01 | 72 | hr | 513 | 530 | 10254 | 0.0517 | 0.0074 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 2 | L01 | 72 | hr | 513 | 578 | 10349 | 0.0558 | 0.0277 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 3 | L01 | 72 | hr | 513 | 604 | 10483 | 0.0576 | 0.0381 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 513 | 626 | 10254 | 0.0610 | 0.0470 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 513 | 677 | 10349 | 0.0654 | 0.0659 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 513 | 723 | 10483 | 0.0690 | 0.0819 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 1 | P23 | 72 | hr | 513 | 741 | 10254 | 0.0723 | 0.0887 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 2 | P23 | 72 | hr | 513 | 791 | 10349 | 0.0764 | 0.1049 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 3 | P23 | 72 | hr | 513 | 817 | 10483 | 0.0779 | 0.1127 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 1 | P22 | 72 | hr | 513 | 698 | 10254 | 0.0681 | 0.0737 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 2 | P22 | 72 | hr | 513 | 761 | 10349 | 0.0735 | 0.0951 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 3 | P22 | 72 | hr | 513 | 752 | 10483 | 0.0717 | 0.0917 |
MCF 10A | Trametinib | 1.11 | uM | LJP5 | 1 | P21 | 72 | hr | 513 | 801 | 10254 | 0.0781 | 0.1085 |
MCF 10A | Trametinib | 1.11 | uM | LJP5 | 2 | P21 | 72 | hr | 513 | 740 | 10349 | 0.0715 | 0.0880 |